Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amidation . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114605308A details a scalable synthesis of 6,6-dimethyl-3-azabicyclo[3.1.0]hexane using dihalo-acyl chloride cyclization, offering significant cost and safety advantages.
Patent CN110577482B reveals a novel 2-step one-pot synthesis for Amisulpride. Discover cost-effective manufacturing, high purity yields, and reliable supply chain solutions.
Patent CN113105354B enables catalyst-free synthesis ensuring high purity and cost efficiency for reliable pharmaceutical intermediates supply chains globally.
Patent CN105016938B reveals efficient N-alkyl amide synthesis. Low catalyst loading and commercial raw materials ensure cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN101481363B reveals a novel amidation route for repaglinide intermediates, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN117945822A reveals a novel iron-mediated amidation method using triazine esters, offering cost-effective and scalable solutions for high-purity pharmaceutical intermediates manufacturing.
Patent CN108997209A offers high-purity Regorafenib synthesis without phosgene. Significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112939796B reveals a high-yield TFMB synthesis route. Discover cost-effective polyimide monomer manufacturing with superior purity and supply stability.
Analyzing patent CN102863370A for high-purity Levetiracetam production. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel route for Iopamidol production via acylated intermediate. High purity, reduced impurities, and cost-effective manufacturing for global supply chains.
Novel anhydride route enhances purity and yield for azulenesulfonamide manufacturing offering significant supply chain stability and cost efficiency advantages.
Patent CN101891794B details a novel ursolic acid piperazine derivative with superior antitumor activity. Discover scalable synthesis routes and cost-effective manufacturing strategies.
Novel method for Lidocaine Hydrochloride Impurity E ensuring high purity and yield for pharmaceutical quality control and supply chain stability.
Discover a novel high-yield route for N-(cyanoalkyl) benzamides. Eliminate nitro reduction steps and acid-binding agents for cost-effective insecticide manufacturing.
Patent CN111018734B reveals a cost-effective route for cinacalcet intermediates using Meldrum's acid, offering reliable supply chain solutions and reduced manufacturing costs for global pharma.
Novel POCl3 condensation method boosts yield to >74% for high-purity biochemical reagents, ensuring reliable supply chain stability.
Patent CN102391169B offers high-purity BPH intermediate synthesis. Ether solvent method ensures safety and scalability for pharmaceutical supply chains.
Patent CN102942521B details a DCC-mediated amidation route for Roflumilast intermediates offering enhanced purity and reduced equipment corrosion for supply chains.
Novel patent CN107382897A enables high-purity Betrixaban intermediate production with reduced waste and enhanced supply chain reliability for global pharmaceutical manufacturers.
Novel preparation method for Tezacaftor via reductive cyclization. High purity, low cost, scalable industrial process for API intermediates.